Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2021 1
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Results by year
Filters applied: . Clear all
Page 1
Administration of antiretroviral medication via enteral tubes.
Prohaska ES, King AR. Prohaska ES, et al. Am J Health Syst Pharm. 2012 Dec 15;69(24):2140-6. doi: 10.2146/ajhp120106. Am J Health Syst Pharm. 2012. PMID: 23230036 Review.
SUMMARY: There is very limited published evidence to guide clinicians in the delivery of therapies for human immunodeficiency virus (HIV) infection by feeding tubes, especially crushed tablets and capsule contents. ...Most of the published evidence (from two prospective st …
SUMMARY: There is very limited published evidence to guide clinicians in the delivery of therapies for human immunodeficiency virus (HIV
Responding to a surge in overdose deaths: perspectives from US syringe services programs.
Frost MC, Austin EJ, Corcorran MA, Briggs ES, Behrends CN, Juarez AM, Frank ND, Healy E, Prohaska SM, LaKosky PA, Kapadia SN, Perlman DC, Schackman BR, Des Jarlais DC, Williams EC, Glick SN. Frost MC, et al. Harm Reduct J. 2022 Jul 19;19(1):79. doi: 10.1186/s12954-022-00664-y. Harm Reduct J. 2022. PMID: 35854351 Free PMC article.
Program Adaptations to Provide Harm Reduction Services During the COVID-19 Pandemic: A Qualitative Study of Syringe Services Programs in the U.S.
Frost MC, Sweek EW, Austin EJ, Corcorran MA, Juarez AM, Frank ND, Prohaska SM, LaKosky PA, Asher AK, Broz D, Jarlais DCD, Williams EC, Glick SN. Frost MC, et al. AIDS Behav. 2022 Jan;26(1):57-68. doi: 10.1007/s10461-021-03332-7. Epub 2021 Jun 10. AIDS Behav. 2022. PMID: 34110506 Free PMC article.
Respondents discussed urgent concerns including reduced reach of services, suspended HIV/hepatitis C testing, high COVID-19 risk among PWUD, and negative impacts of isolation on overdose and mental health. ...
Respondents discussed urgent concerns including reduced reach of services, suspended HIV/hepatitis C testing, high COVID-19 risk amon …
Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020.
Behrends CN, Lu X, Corry GJ, LaKosky P, Prohaska SM, Glick SN, Kapadia SN, Perlman DC, Schackman BR, Des Jarlais DC. Behrends CN, et al. Drug Alcohol Depend. 2022 Mar 1;232:109323. doi: 10.1016/j.drugalcdep.2022.109323. Epub 2022 Jan 20. Drug Alcohol Depend. 2022. PMID: 35124386 Free PMC article.
Approximately three-quarters of SSPs decreased or stopped providing on-site HIV and HCV testing. Nearly half of SSPs offering on-site medications for opioid use disorder (MOUD) in 2019 increased provision of MOUD in 2020. ...CONCLUSIONS: Many SSPs that offered health servi …
Approximately three-quarters of SSPs decreased or stopped providing on-site HIV and HCV testing. Nearly half of SSPs offering on-site …
Syringe Service Program Perspectives on Barriers, Readiness, and Programmatic Needs to Support Rollout of the COVID-19 Vaccine.
Corcorran MA, Austin EJ, Behrends CN, Briggs ES, Frost MC, Juarez AM, Frank ND, Healy E, Prohaska SM, LaKosky PA, Kapadia SN, Perlman DC, Schackman BR, Des Jarlais DC, Williams EC, Glick SN. Corcorran MA, et al. J Addict Med. 2022 Aug 2. doi: 10.1097/ADM.0000000000001036. Online ahead of print. J Addict Med. 2022. PMID: 35916422